Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Proofpoint Expects Pricing IPO In $10-$12/Shr Range - Quick Facts

RELATED NEWS
Trade PFPT now with 

Proofpoint, Inc. said it estimates pricing the initial public offering of its common stock in a range between $10.00 and $12.00 per share.

The company is selling 5 million shares of common stock and the selling stockholders identified in this prospectus are selling 1.199 million shares of common stock. Proofpoint said it will not receive any of the proceeds from the sale of shares of common stock by the selling stockholders.

Prior to this offering, there has been no public market for the company's common stock. Proofpoint has applied to list its common stock on the NASDAQ Global Market under the symbol "PFPT."

The underwriters have the option to purchase from the company a maximum of 750 thousand additional shares and from the selling stockholders a maximum of 179,914 additional shares to cover over-allotments of shares.

Click here to receive FREE breaking news email alerts for Proofpoint, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.